<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_nuwCSex">Response to CBT in pediatric OCD patients does not differ</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Eric</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
							<email>estorch@psychiatry.ufl.edu</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>2</label> Departments of 1 Psychiatry , Pediatrics and</note>
								<orgName type="department" key="dep1">Departments of 1 Psychiatry</orgName>
								<orgName type="department" key="dep2">Pediatrics</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Merlo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Larson</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>3</label> Clinical and Health Psychology , University of Florida , Gainesville , FL and</note>
								<orgName type="department">Clinical and Health Psychology</orgName>
								<orgName type="institution">University of Florida</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Bloss</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>4</label> University of California , San Diego and</note>
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>San Diego</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>2</label> Departments of 1 Psychiatry , Pediatrics and</note>
								<orgName type="department" key="dep1">Departments of 1 Psychiatry</orgName>
								<orgName type="department" key="dep2">Pediatrics</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Jacob</surname></persName>
						</author>
						<author>
							<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
						</author>
						<author>
							<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">San Diego State University Joint Doctoral Program in Clinical Psychology , San Diego , CA , USA</note>
								<orgName type="department">Doctoral Program in Clinical Psychology</orgName>
								<orgName type="institution">San Diego State University Joint</orgName>
								<address>
									<settlement>San Diego</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">Department of Psychiatry , University of Florida , Gainesville , FL 32610 , USA.</note>
								<orgName type="department">Department of Psychiatry</orgName>
								<orgName type="institution">University of Florida</orgName>
								<address>
									<postCode>32610</postCode>
									<settlement>Gainesville</settlement>
									<region>FL</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_uqVd3we">Response to CBT in pediatric OCD patients does not differ</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">0681FB9DD4D1340740FAA308989F1261</idno>
					<idno type="DOI">10.1111/j.1600-0447.2007.01113.x</idno>
					<note type="submission">Accepted for publication September 25, 2007</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T08:57+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_kwQfY62">obsessive-compulsive disorder</term>
					<term xml:id="_YGPC5Ue">symptom dimensions</term>
					<term xml:id="_TZuKTJu">cognitive-behavioural therapy</term>
					<term xml:id="_vc3V58h">children</term>
					<term xml:id="_9q9wRa5">treatment</term>
					<term xml:id="_gAukJ3P">factor analysis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NqMdDky">Symptom dimensions and cognitivebehavioural therapy outcome for pediatric obsessive-compulsive disorder</head><p xml:id="_NGJbWrs"><s xml:id="_JkQSN8y">Obsessive-compulsive disorder (OCD) in children and adolescents is a relatively prevalent disorder (1, 2) that is accompanied by significant disability (3).</s><s xml:id="_XxKykZU">In as many as 80% of cases, symptoms appear in childhood or adolescence (4).</s><s xml:id="_BCgSTPD">Without treatment, pediatric OCD typically runs a chronic Storch EA, Merlo LJ, Larson MJ, Bloss CS, Geffken GR, Jacob ML, Murphy TK, Goodman WK.</s><s xml:id="_ZQEhHSg">Symptom dimensions and cognitivebehavioural therapy outcome for pediatric obsessive-compulsive disorder Objective: To examine whether obsessive-compulsive disorder (OCD) symptom subtypes are associated with response rates to cognitivebehavioural therapy (CBT) among pediatric patients.</s><s xml:id="_KcBdWYE">Method: Ninety-two children and adolescents with OCD (range = 7-19 years) received 14 sessions of weekly or intensive (daily psychotherapy sessions) family-based CBT.</s><s xml:id="_EVMT4Ge">Assessments were conducted at baseline and post-treatment.</s><s xml:id="_hn8NFhF">Primary outcomes included scores on the ChildrenÕs Yale-Brown Obsessive-Compulsive Scale (CY-BOCS), remission status, and ratings on the Clinical Global Improvement (CGI) and Clinical Global Impression -Severity (CGI-Severity) scales.</s><s xml:id="_C7Ewyk7">Results: Seventy-six per cent of study participants (n = 70) were classified as treatment responders.</s><s xml:id="_ec9TKyX">Patients with aggressive ⁄ checking symptoms at baseline showed a trend (P = 0.06) toward improved treatment response and exhibited greater pre ⁄ post-treatment CGI-Severity change than those who endorsed only nonaggressive ⁄ checking symptoms.</s><s xml:id="_ueMUhKp">Step-wise linear regression analysis indicated higher scores on the aggressive ⁄ checking dimension were predictive of treatment-related change in the CGI-Severity index.</s><s xml:id="_dvASxuQ">Regression analysis with CY-BOCS score as the dependent variable showed no difference between OCD subtypes.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_gJP9aAV"><p xml:id="_8emGKDt"><s xml:id="_WYKCVgb">course into adulthood <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b5">6)</ref>.</s><s xml:id="_6jyDvCv">Fortunately, important advances have been made in the pharmacological and psychological interventions for OCD, improving patient treatment and prognosis <ref type="bibr" target="#b6">(7)</ref>.</s></p><p xml:id="_BAWcRxB"><s xml:id="_mxHQjHK">Considering the heterogeneous presentation of adult and pediatric OCD and how this might impact treatment, attention has been paid to symptom subtypes that might have more or less favorable treatment outcomes.</s><s xml:id="_CSHVWAB">Primarily, subtypes have been identified through factor analytic studies of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS; 8, 9) Symptom Checklist.</s><s xml:id="_WWgx5cq">Such studies have produced fairly consistent results, with four-or five-factor solutions comprising dimensions of: i) symmetry ⁄ ordering, ii) contamination ⁄ cleaning, iii) sexual ⁄ religious obsessions, iv) aggressive ⁄ checking, and v) hoarding dimensions <ref type="bibr" target="#b9">(10)</ref>.</s><s xml:id="_TvRY4Qs">It remains unclear if the sexual ⁄ religious obsessions and aggressive ⁄ checking dimensions are a single factor or two separate factors.</s><s xml:id="_SbgBPfE">The limited data for children also support this general factor structure <ref type="bibr" target="#b10">(11)</ref>.</s><s xml:id="_EjJdXCZ">Prospective studies over 2 <ref type="bibr" target="#b11">(12)</ref> and 6 years <ref type="bibr" target="#b12">(13)</ref> have supported the stability of these OCD symptom dimensions.</s></p><p xml:id="_xbZnD5d"><s xml:id="_2szdxMe">To examine differential cognitive-behavioural therapy (CBT) response as a function of patient subtype, several past studies in samples of adult patients have used categorical approaches in which patients are divided into mutually exclusive groups.</s><s xml:id="_ag5emnJ">Patients with hoarding symptoms have shown worse response to CBT <ref type="bibr" target="#b13">(14)</ref> and combined CBT and pharmacotherapy <ref type="bibr" target="#b14">(15)</ref>.</s><s xml:id="_nwswd9h">The presence of primarily obsessional symptoms has also been linked to less favorable CBT outcome <ref type="bibr" target="#b4">(5)</ref>.</s><s xml:id="_3ZGDWzw">Relative to other symptom domains, generally favorable outcomes have been found for washing and checking compulsions <ref type="bibr" target="#b13">(14,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17)</ref>.</s></p><p xml:id="_yJWcbGk"><s xml:id="_hJY6sps">In contrast to the categorical approach, a dimensional approach, which allows patients to potentially be included on multiple dimensions, has unique advantages including improved generalizability (e.g., most patients have multiple symptoms in multiple categories) and feasibility.</s><s xml:id="_DeuwwX6">Yet, only a few studies of this sort have been reported for adult patients.</s><s xml:id="_Zz4ENb4">For example, among 104 adults treated with in-patient CBT, Rufer et al. <ref type="bibr" target="#b17">(18)</ref> found worse response in patients with hoarding symptoms and patients with sexual ⁄ religious obsessions.</s><s xml:id="_wwryru5">Similar results were found in a post-hoc analysis of 153 adults treated with either computer-or clinicianadministered CBT <ref type="bibr" target="#b16">(17)</ref>.</s><s xml:id="_kktPRYz">Finally, in 354 out-patient adults treated with a serotonin reuptake inhibitor, hoarding symptoms were associated with less favorable treatment response <ref type="bibr" target="#b18">(19)</ref>.</s><s xml:id="_25jJN72">To our knowledge, there are no published studies that have explored the relationship between dimensional subgroups of OCD and CBT treatment outcome in pediatric patients.</s><s xml:id="_PFx4XXe">Such work would contribute to the growing literature focused on predicting response to CBT for pediatric OCD by elucidating subtypes with a more favorable or less favorable prognosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_TRYStRd">Aims of the study</head><p xml:id="_DYfhRGc"><s xml:id="_Tfndfwh">In the present study, we examined the extent to which symptom dimensions were associated with CBT response in a sample of youth with OCD.</s><s xml:id="_GgN98wH">Based on results of studies examining adult OCD patients, we predicted that higher scores on the hoarding and the sexual ⁄ religious obsessions dimension would predict less favorable CBT response.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_n3V2ywT">Material and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_RU3SSvB">Participants</head><p xml:id="_Wz8G5rw"><s xml:id="_VnvUFJx">Participants included 92 children and adolescents ages 7-19 years old (mean = 13.6 ± 3.3) who consecutively presented for CBT at the University of Florida OCD Program over the period of 2003-2005.</s><s xml:id="_dx67xW5">Fifty-three per cent were male (n = 49), and the majority of participants were Caucasian in ethnicity (n = 87), followed by Asian (n = 3) and Hispanic (n = 2).</s><s xml:id="_53X9Qyr">Inclusion criteria were: i) principal diagnosis of OCD and ChildrenÕs Yale Brown Obsessive-Compulsive Scale (CY-BOCS; 20) Total Score ‡16; ii) no change in psychotropic medication (if applicable) for at least 8 weeks prior to study entry; and, iii) availability of at least one parent to accompany the child to all sessions.</s><s xml:id="_PgeJVfG">Exclusion criteria were: i) history of and ⁄ or current psychosis, bipolar disorder, or current suicidality; ii) principal diagnosis other than OCD; iii) diagnosis of autism or mental retardation based on records review and clinical interview; iv) in concurrent psychotherapy of any kind; and v) caregiver diagnosis of mental retardation, psychosis, or other psychiatric disorders or conditions that would limit their ability to participate in their childÕs treatment.</s><s xml:id="_pYqeBFt">Fifty-nine per cent of youth had a comorbid psychiatric condition, with the specific comorbidities as follows -generalized anxiety disorder (n = 33), major depression (n = 24), attention deficit hyperactivity disorder (n = 23), oppositional defiant disorder (n = 14), social phobia (n = 14), TouretteÕs syndrome (n = 9), panic disorder (n = 5), and trichotillomania (n = 1).</s><s xml:id="_cz8EBcM">Forty-three per cent of youth had more than one comorbidity.</s><s xml:id="_CX2N9KY">Sixty-four per cent of subjects (n = 59) were on psychotropic medication for their OCD at the baseline assessment.</s><s xml:id="_rgQS68b">Medications consisted of varied selective serotonin reuptake inhibitors, with a minority of children also on atypical antipsychotics (n = 17).</s><s xml:id="_Zm7KdGv">Medication remained stable throughout the course of treatment and participants were not allowed to receive concurrent psychotherapy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8sHHa9P">Measures</head><p xml:id="_AU6BEdF"><s xml:id="_yTH4Tsr">Anxiety Disorder Interview Schedule for Children -Parent Version.</s><s xml:id="_Pc9mGnw">The ADIS-IV-P ( <ref type="formula">21</ref>) is a semi-structured diagnostic interview that assesses DSM-IV anxiety, mood, and externalizing disorders in youth.</s><s xml:id="_SxDkurJ">Diagnoses are based on symptom endorsement and a severity rating of ‡4 on an 8point scale.</s><s xml:id="_XD4zg3u">Studies investigating the psychometric properties have shown positive results <ref type="bibr" target="#b21">(22,</ref><ref type="bibr" target="#b22">23)</ref>.</s></p><p xml:id="_hUMRDYe"><s xml:id="_kgTCWZX">ChildrenÕs Yale Brown Obsessive Compulsive Scale.</s><s xml:id="_Xg6gyc9">-Based on the adult Yale-Brown Obsessive-Compulsive Scale <ref type="bibr" target="#b7">(8,</ref><ref type="bibr" target="#b8">9)</ref>, the CY-BOCS ( <ref type="formula">20</ref>) is a 10-item, clinician-rated semi-structured interview that assesses OCD symptom severity over the past week.</s><s xml:id="_WwjbXVN">The CY-BOCS includes the following four sections -Obsessions Checklist, Severity Items for Obsessions, Compulsions Checklist, and Severity Items for Compulsions.</s><s xml:id="_EchgbPa">From these sections, an Obsession Severity score (five items), Compulsion Severity score (five items), and Total Score (sum of all 10 items) are yielded.</s><s xml:id="_KfK6wd4">On the Obsessions and Compulsions Symptom Checklists, 54 obsessions and compulsions are rated for their current and past presence (scored as 1) or absence (scored as 0).</s><s xml:id="_Bm5htbG">Considered the Ôgold standardÕ for pediatric OCD assessment, the CY-BOCS has strong supporting reliability and validity data <ref type="bibr" target="#b19">(20,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b24">25)</ref> and documented treatment sensitivity <ref type="bibr" target="#b25">(26)</ref><ref type="bibr" target="#b26">(27)</ref><ref type="bibr" target="#b27">(28)</ref>.</s></p><p xml:id="_35thTUX"><s xml:id="_Fek7yGh">Clinical Global Improvement.</s><s xml:id="_cRFB9Md">The Clinical Global Improvement scale (CGI; 29) reflects the evalua-torÕs assessment of treatment progress relative to the baseline assessment.</s><s xml:id="_CRXNZgD">The CGI is rated on a 7point scale ranging from 1 (very much improved) to 7 (very much worse).</s><s xml:id="_qPj3ehx">For the current study, treatment response was defined as receiving a rating of Ôvery much improvedÕ or Ômuch improved.Õ Clinical Global Impression-Severity.</s><s xml:id="_YA2uFXB">The Clinical Global Impression -Severity scale (CGI-S; 30) is a clinician rating of symptom severity.</s><s xml:id="_WhkNFb9">Ratings range from 1 (Ôno illnessÕ) to 7 (Ôextremely severeÕ).</s><s xml:id="_3U3Fq3b">The CGI-S correlates strongly with the CY-BOCS Total Score (r = 0.75) in pediatric OCD patients <ref type="bibr" target="#b23">(24)</ref>, and is widely used and treatment sensitive <ref type="bibr" target="#b26">(27,</ref><ref type="bibr" target="#b27">28)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_52uuGfY">Procedures</head><p xml:id="_prxgA5t"><s xml:id="_z53f82X">The procedures for this study were approved by the University of Florida Institutional Review Board.</s><s xml:id="_5TvyYSz">All participants had a principal diagnosis of OCD, according to DSM-IV-TR (31) criteria, made by the first or second author.</s><s xml:id="_cNkH2Ws">Diagnoses were made using best-estimate procedures <ref type="bibr" target="#b31">(32)</ref>, which included an unstructured clinical interview by the first or second author, results from the ADIS-IV-P and CY-BOCS.</s><s xml:id="_2y2Nrkd">Ninety-nine per cent (92 ⁄ 93) of families agreed to participate in study-related procedures.</s><s xml:id="_GvktdE8">Baseline demographic and clinical characteristics of the sample are included in Table <ref type="table" target="#tab_0">1</ref>.</s></p><p xml:id="_kKa4KRb"><s xml:id="_Mp4SCUk">Assessments.</s><s xml:id="_HqgPnAa">After obtaining appropriate written consent and assent, trained masters or doctoral level clinical psychology doctoral students administered clinician-rated measures (ADIS-IV-P, CY-BOCS, CGI-S) to parents and children jointly.</s><s xml:id="_wrCFnHC">Clinician ratings were based on parent and child responses, as well as clinician judgment and behavioural observation of the child.</s><s xml:id="_Z9RWafF">The first author trained all raters in measurement administration as follows: i) direct instruction, ii) observation of at least three training cases, iii) administration of three batteries under direct supervision.</s><s xml:id="_rTmeQys">To evaluate inter-rater reliability, the CY-BOCS was readministered to 20 children and their parents at baseline; inter-rater reliability was high for the total score (kappa = 0.96).</s><s xml:id="_4KxxGmd">Following administration of clinician-rated measures, parents and children completed secondary measures that are not reported in this study.</s><s xml:id="_DgE7Sbu">Immediately following treatment, these assessment procedures were replicated for each patient.</s><s xml:id="_phwXYHf">The literature on symptom dimensions has produced generally consistent results, with studies among adults showing four-or five-factor solutions.</s><s xml:id="_W9b9CvM">Generally, the symptom dimensions of contamination ⁄ washing, symmetry ⁄ ordering, and hoarding were consistent across studies.</s><s xml:id="_QhDUU8Y">However, some studies found that the aggressive ⁄ checking and sexual ⁄ religious dimensions form a single factor <ref type="bibr" target="#b32">(33,</ref><ref type="bibr" target="#b33">34)</ref> whereas others have found support for separate factors <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b35">36)</ref>.</s><s xml:id="_FAhpmUb">Given that the evidence reviewed in Mataix-Cols et al. <ref type="bibr" target="#b9">(10)</ref> supports the validity of a five-factor model of symmetry ⁄ ordering, contamination ⁄ cleaning, sexual ⁄ religious obsessions, aggressive ⁄ checking, and hoarding, and that Mataix-Cols et al. <ref type="bibr" target="#b16">(17)</ref> and Rufer et al. <ref type="bibr" target="#b17">(18)</ref> used these dimensions in their analyses (thus, enhancing comparability of results), we chose to use the five-factor dimensional model of OCD.</s><s xml:id="_SWpGnEJ">Consistent with Mataix-Cols et al. <ref type="bibr" target="#b16">(17)</ref> and Rufer et al. <ref type="bibr" target="#b17">(18)</ref>, the current presence of a primary symptom on the CY-BOCS Symptom Checklist was coded as 1; its absence was coded as 0. Scores on the five-factor analytically derived symptom dimensions (symmetry ⁄ ordering, contamination ⁄ cleaning, sexual ⁄ religious obsessions, aggressive ⁄ checking, and hoarding) were derived by summing the scores of the symptom categories for each dimension.</s></p><p xml:id="_qqYVqne"><s xml:id="_K73ZNGf">Cognitive-behavioural therapy.</s><s xml:id="_XSKhTKu">Participants received weekly (n = 48) or intensive (n = 42) familybased CBT.</s><s xml:id="_BeRqR5e">For 40 youth, the treatment format was based on their participation in a study involving a randomized comparison of weekly and intensive CBT <ref type="bibr" target="#b27">(28)</ref>; for the others, this was based on clinical appropriateness.</s><s xml:id="_pj6M6sa">At baseline, weekly and intensive treatment patients differed on mean age (intensive: 12.4 years; weekly 14.7 years; t(90) = 2.55, P &lt; 0.02) and CGI-S score (intensive CGI = 5.2; weekly CGI = 4.8; t(90) = 3.46, P &lt; 0.01).</s><s xml:id="_QWXcgj4">Groups did not differ on gender ratio or number of participants with comorbid conditions (both v 2 &lt; 1.15, P &gt; 0.28) nor did they differ on CY-BOCS Total Score, CY-BOCS Obsessions Scale, CY-BOCS Compulsion Scale, mean household income, or any symptom dimensions (all t-values &lt;1.73, all P-values &gt;0.09).</s><s xml:id="_EgsqME5">In addition, medication was equally distributed across groups (v 2 = 1.46,</s><s xml:id="_ua2MBBY">P = 0.23), and no outcome differences as measured by the CGI-S, CGI-I, and CY-BOCS were found across intensive or weekly conditions (t-values &lt;1.42, P-values &gt;0.16).</s><s xml:id="_ZF6pd4e">Thus, in order to achieve adequate statistical power for the analyses of interested, intensive and weekly treatment groups were combined.</s></p><p xml:id="_6kEapHG"><s xml:id="_TXF2qxW">Therapy included 14 individual 90-min CBT sessions in either a weekly (once per week) or intensive (14 sessions over 3 weeks) format.</s><s xml:id="_nwHFXdS">Therapists were clinical child psychology postdoctoral fellows and ⁄ or doctoral candidates who were under the first authorÕs supervision.</s><s xml:id="_cyjgvAC">All therapists had treated at least three OCD cases prior to serving as a therapist.</s><s xml:id="_28ByAXq">Training included guided reading of the treatment protocol, and completing at least three training cases with integrity checks independently under supervision.</s><s xml:id="_4cfcHjr">Supervision was held between sessions and as needed otherwise.</s><s xml:id="_fMGtXet">Sessions were conducted according to a modified version of the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS; 27) manual and included psychoeducation, cognitive training, and exposure with response prevention (E ⁄ RP).</s><s xml:id="_pTMrsdc">Slightly different from the original POTS protocol, sessions were delivered in a Ôfamily-basedÕ format, with at least one parent attending all sessions with the patient.</s><s xml:id="_P7uPUmB">Consistent with work by Freeman et al. <ref type="bibr" target="#b36">(37)</ref>, parents were included in the treatment to facilitate understanding of treatment principles, to assist with generalization of treatment gains by enlisting the parent as an at-home Ôcoach,Õ to reduce parent accommodation of OCD symptoms, and to encourage optimal effort by the child during in-session exposures and homework assignments.</s><s xml:id="_q8hAfbZ">During the first three sessions, the cognitivebehavioural model of OCD was discussed.</s><s xml:id="_A5PnMsj">An exposure and response prevention hierarchy was also created, which ranked ritual-producing stimuli from least to most distressing on the Subjective Units of Distress Scale.</s><s xml:id="_UZyVHyU">In session 4, the child selected a trial exposure of relative ease.</s><s xml:id="_AawKRXq">Thereafter, CBT sessions consisted of gradual exposure (both imaginal and in vivo) to hierarchy items, with instructions for strict abstinence from compulsions.</s><s xml:id="_uNsEGHg">Early exposures were to moderately distressing situations with progression toward more anxiety-provoking ones.</s><s xml:id="_HwkEtQ4">During exposures, therapists directed attention to youthsÕ mistaken cognitions about the likelihood of catastrophic consequences.</s><s xml:id="_SQqEfne">Between-session homework was assigned ( ‡60 min daily) consisting of exposures to stimuli similar to those addressed in session.</s><s xml:id="_w5PKhZK">Parts of the final two sessions were used to prepare the patient to manage symptoms independently.</s><s xml:id="_Grv9ecP">Potential barriers and problem situations were also reviewed, accompanied by a discussion of the appropriate action.</s><s xml:id="_sW3rcCA">Treatment plans were individually tailored to address patient-specific symptoms, as well as other needs (e.g., family accommodation, oppositionality, parent-child communication problems, developmental needs).</s><s xml:id="_r32vrvq">For younger children, fewer and less sophisticated cognitive components were included in the treatment.</s><s xml:id="_8WyWrQ9">Additionally, younger children often required more parental involvement (e.g., reduced accommodation) and contingency management strategies (e.g., rewards for participation in E ⁄ RP exercises).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WjAUCfw">Data analysis</head><p xml:id="_QT6S5RZ"><s xml:id="_3Y9Yjbz">As only 7 out of 92 participants dropped out of treatment and the primary reason for drop-out was lack of improvement, we used last observation forward analyses to account for missing data at the post-treatment assessment.</s><s xml:id="_kgEgr7S">A within-subjects, repeated-measures analysis of variance was employed to examine changes in CY-BOCS Total Score, CY-BOCS Obsession Severity, and CY-BOCS Compulsion Severity from baseline to posttreatment.</s><s xml:id="_drKx6NC">Response to CBT was defined as a rating of 1 (very much improved) or 2 (much improved) on the CGI at post-treatment.</s><s xml:id="_mwVNfQp">PearsonÕs chi-squared and independent samples t-tests were used for between-group (treatment responders vs. treatment non-responders) comparisons.</s><s xml:id="_YE5ASpd">For both categorical and dimensional OCD subtype analyses, endorsement of any symptoms within a particular dimension was sufficient for inclusion in that subgroup; thus, patients were included in multiple subgroups.</s><s xml:id="_usYvTE3">For dimensional analysis of OCD symptom subgroups, we utilized the approach of Rufer et al. <ref type="bibr" target="#b17">(18)</ref>, where variables representing symptom severity for each of the five symptom dimensions of the CY-BOCS were computed separately for each dimension (i.e., hoarding: range 0-2 symptoms, symmetry ⁄ arranging: range 0-5 symptoms, contamination: range 0-13 symptoms, sexual ⁄ religious: range 0-5 symptoms, and aggression ⁄ checking: range 0-12 symptoms).</s><s xml:id="_TP4UAC4">The use of dimensional subgroups and subsequent inclusion of single participants in multiple groups renders omnibus between-group tests inappropriate because of violations of the assumption of group independence.</s><s xml:id="_Mta3qW6">Thus, separate PearsonÕs chisquared analyses within each symptom endorsement group (e.g., patients who endorsed hoarding symptoms compared with patients who did not endorse hoarding symptoms) were performed on treatment response data.</s><s xml:id="_U4NRuhW">In addition, separate independent samples t-tests were used for comparisons of CY-BOCS and CGI-Severity pre ⁄ posttreatment difference scores.</s><s xml:id="_gmU6mnk">We then conducted a stepwise binary logistic regression analysis using forward technique to examine dimensional predictors of treatment response or non-response.</s><s xml:id="_UtDKXYN">Two subsequent step-wise linear regression analyses using forward technique were conducted to examine OCD symptom dimensions as potential predictors of pre ⁄ post-treatment changes in CGI-Severity and CY-BOCS Total Scores.</s><s xml:id="_9UqfQmt">For each stepwise regression, factors with an F-value lower than 3.84 (P = 0.05) were eliminated.</s><s xml:id="_nxk7JM2">Due to the exploratory nature of this study, all significance values were set at P &lt; 0.05 (two-sided).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_N6TCy5A">Results</head><p xml:id="_ruEECab"><s xml:id="_DkRCYhQ">Baseline demographic and clinical characteristics of study participants are listed in Table <ref type="table" target="#tab_0">1</ref>.</s><s xml:id="_5QYZkjS">The most frequent symptoms observed in this sample were contamination and aggressive obsessions, rituals involving other persons, and washing ⁄ cleaning and checking compulsions.</s><s xml:id="_58fsm3W">Participants generally displayed a significant decrease from baseline to post-treatment on CGI-Severity [4.9 ± 0.9 to 2.9 ± 1. Seventy-six per cent of study participants (n = 70) were classified as treatment responders based upon a CGI-Improvement rating of 1 or 2. Demographic information, chi-squared or t-values, and significance level for analyses as a function of treatment response group are presented in Table <ref type="table" target="#tab_1">2</ref>. Treatment responders and non-responders did not differ on the demographic variables of sex, age, or family income, nor did they differ in the number of patients with comorbid diagnoses, baseline CGI-Severity or CY-BOCS Total, Obsession Severity, or Compulsions Severity scores.</s><s xml:id="_jU4h4KT">As expected, treatment responders showed significant decreases in CGI-Severity and all CY-BOCS scores relative to non-responders.</s></p><p xml:id="_pXexafV"><s xml:id="_PCR5xHC">Results of pre ⁄ post-treatment outcome measures as a function of OCD symptom group are presented in Table <ref type="table" target="#tab_2">3</ref>.</s><s xml:id="_rpysGAF">In order to examine group response to treatment, separate chi-squared analyses were conducted using treatment response status as the dependent variable and categorical OCD symptom group (e.g., patients with aggressive ⁄ checking symptoms vs. patients without aggressive ⁄ checking symptoms) as the independent variable.</s><s xml:id="_4zQfxUd">Results indicated that patients with aggressive ⁄ checking symptoms at baseline showed a trend toward being more likely to respond to treatment than those who endorsed only nonaggressive ⁄ checking symptoms (v 2 (1) = 3.4,</s><s xml:id="_99Ts2QU">P = 0.06).</s><s xml:id="_PzE2Cg7">No differences in the per cent of treatment responders were found for those who differentially endorsed hoarding, symmetry ⁄ order, contamination, or sexual ⁄ religious symptoms and those who did not (all chi-squared values &lt; 1.3, all P-values &gt;0.26).</s><s xml:id="_PQ5g8NX">Similarly, separate independent samples t-tests were conducted using the pre ⁄ posttreatment difference score for CGI-Severity or CY-BOCS Total Score as the dependent variable, and symptom group as the independent variable.</s><s xml:id="_bx7QqDe">Results of the t-tests for each categorical symptom endorsement group indicated patients who endorsed aggressive ⁄ checking symptoms had greater pre ⁄ post-treatment CGI-Severity change than those who did not endorse such symptoms (t(90) = 2.0, P &lt; 0.05); the same difference was not reliable for CY-BOCS difference score (t(90) = 1.2, P = 0.22).</s><s xml:id="_dgsPEhM">No differences on pre ⁄ post-change scores for either the CGI-Severity index or CY-BOCS Total Score were found for the other four symptom endorsement groups (all t-values &lt;0.97, all P-values &gt;0.34].</s></p><p xml:id="_rzF4qjA"><s xml:id="_42ApaXR">To examine the symptom dimensions continuously, rather than as categorical variables, partic-ipantsÕ dimensional scores for each OCD subtype (e.g., symmetry ⁄ ordering, contamination ⁄ cleaning, sexual ⁄ religious obsessions, aggressive ⁄ checking, and hoarding) were first entered into a stepwise binary logistic regression with treatment response (defined as a post-treatment CGI-S score of Ôvery muchÕ or ÔmuchÕ improved) as the dependent variable and OCD symptom dimensional scores as the independent variables.</s><s xml:id="_VqFBCSg">Two subsequent separate step-wise linear regressions with the dependent variables of pre ⁄ post-treatment difference score on the CGI-Severity index and pre ⁄ post-treatment differences score on the CY-BOCS, respectively, as the dependent variables were also conducted.</s><s xml:id="_QcqQJdu">For the stepwise logistic regression, no significant predictors were retained in the model based on our established criteria.</s><s xml:id="_fF9RrKS">Subsequent linear regression analyses indicated that higher scores on the aggressive ⁄ checking dimension were predictive of treatment-related change in the CGI-Severity index (b = 0.34, P &lt; 0.05, 95% CI = 0.01-0.66).</s><s xml:id="_8nueHhs">No significant predictors were retained in the model for the second regression predicting pre ⁄ post-treatment change in CY-BOCS Total Score.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_YhuSKK8">Discussion</head><p xml:id="_E76rssb"><s xml:id="_7EqGftm">The present study examined cognitive behavioural therapy outcome among children and adolescents with varying symptom subtypes of OCD (i.e., symmetry ⁄ ordering, contamination ⁄ cleaning, sexual ⁄ religious obsessions, aggressive ⁄ checking, and hoarding symptoms).</s><s xml:id="_8sChrht">In general, CBT was effective for youth with all symptom subtypes.</s><s xml:id="_P2FMJ6Y">In fact, the overwhelming majority (76%) were rated as Ômuch improvedÕ or Ôvery much improvedÕ after 14 CBT sessions, supporting the assertion that CBT should be recommended as the first-line treatment for youth with OCD (e.g., 27), regardless of presenting symptoms.</s><s xml:id="_WUA9PbK">However, the consistently observed positive treatment response among the current sample created a Ôceiling effect,Õ making between-group comparisons of treatment outcome difficult to detect.</s><s xml:id="_bEVNGdr">For example, although similar studies in adults indicated less favorable treatment outcome among patients with hoarding symptoms or sexual ⁄ religious symptoms <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b17">18)</ref>, these differences were not statistically significant in the present study.</s><s xml:id="_TekDJuT">It is noteworthy that youth with hoarding symptoms displayed the lowest treatment response rates (i.e., 64.3%), followed by youth with sexual ⁄ religious symptoms (i.e., 72.5%).</s><s xml:id="_4ttFYsk">Unfortunately, given the relatively small number of study participants (e.g., only 14 youth displayed hoarding symptoms), the analyses were not adequately powered to support our hypotheses.</s></p><p xml:id="_xDGupnM"><s xml:id="_K4kAtsd">The present results suggest that some of the same factors affecting adult OCD patients with these symptoms (e.g., poor insight) may affect pediatric OCD patients as well.</s><s xml:id="_wGt9czg">Patients with hoarding symptoms or primarily religious symptoms may have more difficulty recognizing the irrational nature of their symptoms than other patients, likely due to the longer delay between the anxietyprovoking stimulus and the feared consequences.</s><s xml:id="_j5wJ7uW">For example, while patients with contamination symptoms may be concerned about becoming sick immediately following contact with a contaminated object, patients with hoarding symptoms may worry about throwing an item away in case they need it weeks, months, or years later.</s><s xml:id="_DXee8HE">Similarly, patients with religious obsessions are typically more concerned about long-term consequences (e.g., suffering post-mortem for eternity) than short-term consequences.</s><s xml:id="_cpUXNxM">As a result, these beliefs are more difficult to challenge and ⁄ or disprove, because the feared consequence could still occur long after the exposures have been completed.</s></p><p xml:id="_hRtDENN"><s xml:id="_7W692Q6">On the other hand, the group of children presenting with aggressive ⁄ checking symptoms stood out as significantly more likely that the others to respond to treatment, with 82% displaying positive treatment response.</s><s xml:id="_uNtga55">Applying the same logic, the length of time between the onset of the obsession and the feared consequence is typically quite short.</s><s xml:id="_EbbURrP">Anxiety levels typically fall quickly when the individual refrains from engaging in a checking compulsion and no negative consequence occurs.</s><s xml:id="_Mam3y8B">Similarly, individuals who are afraid of acting out an aggressive impulse typically learn quickly upon exposure to the feared stimulus that they are able to maintain control.</s><s xml:id="_rMbs4gq">Building upon operant conditioning theory <ref type="bibr" target="#b37">(38)</ref>, these symptoms may be more amenable to extinction with exposure and response-prevention, because of the close temporal connection between behavior (e.g., exposure) and punishment (e.g., feared consequence).</s><s xml:id="_QTmXPMa">Participation in the exposure, followed immediately by negative reinforcement (e.g., gradually decreasing anxiety), results in increased willingness to engage in future exposures.</s></p><p xml:id="_dfehFQu"><s xml:id="_CaTmmtb">Some limitations of the study should be noted.</s><s xml:id="_pcVe7RY">First, in order to achieve adequate statistical power we combined OCD patients who were treated with either intensive or weekly CBT.</s><s xml:id="_CNa4SCd">However, groups did not differ on post-treatment response variables or any symptom dimensions, but they did differ on initial CGI-S score.</s><s xml:id="_UjPBBQA">It is possible, however, that results are biased by the type of treatment received, which may be one explanation for the inconsistency of these data with past adult studies <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b17">18)</ref>.</s><s xml:id="_Fyxn2WJ">Second, the sample was composed of a relatively homogeneous group of individuals; namely, primarily Caucasian youth from upper middle-class backgrounds who presented to a specialty treatment clinic for OCD.</s><s xml:id="_4jyDJYP">As a result, the results may not generalize to the population of youth with OCD as a whole.</s><s xml:id="_au82d4F">Third, as noted previously, the limited number of participants presenting with certain symptom subtypes (e.g., hoarding) likely resulted in the analyses for that group being underpowered.</s><s xml:id="_wS8Sfm9">Fourth, in an effort to broadly cover possible treatment outcomes, the CGI, CGI-S, and CY-BOCS all were utilized as outcome measures.</s><s xml:id="_3BExYSd">Finding differences in treatment response as a function of symptom dimension in the CGI-S, but not CY-BOCS, shows some inconsistency in OCD severity measurement.</s><s xml:id="_MvY7qc4">However, it is common in clinical trials to utilize both the CGI scales and CY-BOCS as outcome measures (e.g., <ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40)</ref>.</s><s xml:id="_72TvEKB">Furthermore, studies have found a strong, but not perfect, relationship between the CGI-S and CY-BOCS <ref type="bibr" target="#b23">(24)</ref> suggesting that these scales assess overlapping but somewhat different constructs.</s><s xml:id="_ZDauNUz">Factor analytic studies of the CY-BOCS and Y-BOCS have identified separate dimensions of illness severity and symptom resistance ⁄ control <ref type="bibr" target="#b40">(41)</ref><ref type="bibr" target="#b41">(42)</ref><ref type="bibr" target="#b42">(43)</ref> with data suggesting that the severity dimension is more strongly related to the CGI-S rating than resistance ⁄ control <ref type="bibr" target="#b41">(42)</ref>.</s><s xml:id="_Nx5RANn">Thus, while the CGI-S and the CY-BOCS tend to be highly correlated there are differences in the constructs that they measure.</s><s xml:id="_UzmsEZU">Finally, there was significant overlap among symptom categories, with most patients displaying multiple symptoms.</s><s xml:id="_ZYBApBQ">Although this may result in more ecologically valid analyses (i.e., most patients presenting for treatment have multiple symptoms), it prevented us from examining between-group differences because groups were not independent.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc><div><p xml:id="_V3x6SGJ"><s xml:id="_eusT6Cf">3; F(1,91) = 191.3,</s><s xml:id="_csuWQNe">P &lt; 0.001], CY-BOCS Total Score [27.4 ± 5.9 to 11.8 ± 90.0; F(1, 91) = 278.2,</s><s xml:id="_XeTmFVV">P &lt; 0.001], CY-BOCS Obsession Severity score [13.6 ± 3.3 to 6.3 ± 4.5; F(1, 91) = 237.8,</s><s xml:id="_jdv8fEH">P &lt; 0.001], and CY-BOCS Compulsion Severity score [13.8 ± 3.2 to 5.5 ± 4.9; F(1, 91) = 277.0,</s><s xml:id="_7PCCVeR">P &lt; 0.001].</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_uvtvq6j"><s xml:id="_UGtazzj">Baseline demographic and clinical characteristics in 92 children and adolescents with OCD</s></p></div></figDesc><table><row><cell>Variables</cell><cell>Mean (SD)</cell></row><row><cell>Age in years</cell><cell>13.6 (3.3)</cell></row><row><cell></cell><cell>Number of OCD patients, n (%)</cell></row><row><cell>Gender, female ⁄ male</cell><cell>43 ⁄ 49 (46.7 ⁄ 53.3)</cell></row><row><cell>Frequencies of obsessions on the</cell><cell></cell></row><row><cell>CY-BOCS Symptom Checklist (%)</cell><cell></cell></row><row><cell>Contamination</cell><cell>48 (52.2)</cell></row><row><cell>Aggressive</cell><cell>30 (32.6)</cell></row><row><cell>Somatic</cell><cell>29 (31.5)</cell></row><row><cell>Religious</cell><cell>20 (21.7)</cell></row><row><cell>Sexual</cell><cell>19 (20.7)</cell></row><row><cell>Hoarding</cell><cell>11 (12.0)</cell></row><row><cell>Magical thoughts ⁄ superstitions</cell><cell>9 (9.8)</cell></row><row><cell>Frequencies of compulsions on the</cell><cell></cell></row><row><cell>CY-BOCS Symptom Checklist (%)</cell><cell></cell></row><row><cell>Rituals involving other persons</cell><cell>35 (38.0)</cell></row><row><cell>Washing ⁄ cleaning</cell><cell>33 (35.9)</cell></row><row><cell>Checking</cell><cell>31 (33.7)</cell></row><row><cell>Order ⁄ arranging</cell><cell>25 (27.2)</cell></row><row><cell>Repeating</cell><cell>24 (26.1)</cell></row><row><cell>Counting</cell><cell>21 (22.8)</cell></row><row><cell>Hoarding</cell><cell>13 (14.1)</cell></row><row><cell>Magical ⁄ superstitious behavior</cell><cell>5 (5.4)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_7CRWrJm"><s xml:id="_hmyErTw">Demographic and pre ⁄ post-treatment clinical characteristics as a function of treatment response group.</s><s xml:id="_WTmdjdY">Data include mean (SD) unless otherwise specified</s></p></div></figDesc><table><row><cell>Demographic Variable</cell><cell>Response (n = 70)</cell><cell>Non-response (n = 22)</cell><cell>t or v 2</cell><cell>P-value</cell></row><row><cell>Sex (male), n (%)</cell><cell>37 (53)</cell><cell>12 (55)</cell><cell>0.02</cell><cell>0.89</cell></row><row><cell>Age</cell><cell>13.6 (3.5)</cell><cell>13.7 (2.9)</cell><cell>)0.15</cell><cell>0.88</cell></row><row><cell>Family income</cell><cell>85 703 (44 993)</cell><cell>87 000 (36 898)</cell><cell>)0.11</cell><cell>0.91</cell></row><row><cell>Comorbid condition present, n (%)</cell><cell>39 (56)</cell><cell>15 (68)</cell><cell>1.1</cell><cell>0.30</cell></row><row><cell>Baseline CGI-Severity</cell><cell>5.0 (.9)</cell><cell>4.9 (.9)</cell><cell>0.44</cell><cell>0.66</cell></row><row><cell>Baseline CY-BOCS Total Score</cell><cell>27.5 (5.8)</cell><cell>27.3 (6.7)</cell><cell>0.15</cell><cell>0.88</cell></row><row><cell>Baseline CY-BOCS Obsession Severity</cell><cell>13.6 (3.1)</cell><cell>13.5 (4.2)</cell><cell>0.18</cell><cell>0.86</cell></row><row><cell>Baseline CY-BOCS Compulsion Severity</cell><cell>13.8 (3.1)</cell><cell>13.8 (3.5)</cell><cell>0.01</cell><cell>0.99</cell></row><row><cell>Post-CGI-Severity</cell><cell>2.4 (.8)</cell><cell>4.7 (1.1)</cell><cell>)10.7</cell><cell>0.001</cell></row><row><cell>Post-CY-BOCS Total</cell><cell>7.9 (5.1)</cell><cell>24.0 (7.9)</cell><cell>)11.2</cell><cell>0.001</cell></row><row><cell>Post-CY-BOCS Obsession Severity</cell><cell>4.5 (2.7)</cell><cell>12.0 (4.2)</cell><cell>)10.0</cell><cell>0.001</cell></row><row><cell>Post-CY-BOCS Compulsion Severity</cell><cell>3.5 (2.8)</cell><cell>12.0 (4.6)</cell><cell>)10.5</cell><cell>0.001</cell></row><row><cell>Pre ⁄ post-difference CGI-Severity</cell><cell>2.6 (1.1)</cell><cell>0.2 (0.6)</cell><cell>9.9</cell><cell>0.001</cell></row><row><cell>Pre ⁄ post-difference CY-BOCS Total</cell><cell>19.6 (5.9)</cell><cell>3.2 (4.9)</cell><cell>0.11.8</cell><cell>0.001</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_BC797he"><s xml:id="_RvgrrJF">Clinical improvement for OCD patients within each symptom endorsement group.</s><s xml:id="_WWr4kmk">Data include mean (SD) unless otherwise specified</s></p></div></figDesc><table><row><cell></cell><cell>CGI-Severity</cell><cell></cell><cell cols="2">CY-BOCS Total Score</cell><cell></cell></row><row><cell>Symptom endorsement group</cell><cell>Baseline</cell><cell>Post</cell><cell>Baseline</cell><cell>Post</cell><cell>Response rate (%)</cell></row><row><cell>Hoarding (n = 14)</cell><cell>5.1 (1.0)</cell><cell>3.0 (1.7)</cell><cell>29.6 (5.8)</cell><cell>14.9 (11.7)</cell><cell>64.3</cell></row><row><cell>Symmetry ⁄ order (n = 44)</cell><cell>5.1 (0.9)</cell><cell>2.9 (1.5)</cell><cell>28.5 (5.5)</cell><cell>12.4 (10.3)</cell><cell>75.0</cell></row><row><cell>Contamination (n = 48)</cell><cell>4.9 (1.0)</cell><cell>2.9 (1.2)</cell><cell>27.6 (6.2)</cell><cell>12.0 (8.6)</cell><cell>77.1</cell></row><row><cell>Sexual ⁄ religion (n = 51)</cell><cell>5.1 (1.0)</cell><cell>3.0 (1.3)</cell><cell>28.0 (5.8)</cell><cell>12.0 (9.0)</cell><cell>72.5</cell></row><row><cell>Aggression ⁄ checking (n = 61)</cell><cell>5.1 (0.9)</cell><cell>2.8 (1.3)</cell><cell>27.5 (6.2)</cell><cell>11.1 (8.8)</cell><cell>82</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_w6g7EMz"><s xml:id="_mVFxRuh">16000447, 2008, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.2007.01113.x</s><s xml:id="_fTsX9kv">by University Of Iowa Libraries -Serials Acquisitions, Wiley Online Library on [17/07/2025].</s><s xml:id="_tZEQC4b">See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions)</s><s xml:id="_vjaykcM">on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_FNDhEcB">Acknowledgement</head><p xml:id="_UNa4vXb"><s xml:id="_qpqWQN2">The contributions of <rs type="person">Emily Ricketts</rs> and <rs type="person">Valerie Crawford</rs> are acknowledged.</s></p></div>
			</div>			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HTuajH4">Declaration of interest</head><p xml:id="_jNhejka"><s xml:id="_DRsuXvc">The authors have no competing interests with this study.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_VwY4A9A">Obsessive-compulsive syndromes in older adolescents</title>
		<author>
			<persName><forename type="first">G</forename><surname>Maina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Albert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bogetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ravizza</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-0447.1999.tb10895.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Tq7NrEb">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="447" to="450" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maina G, Albert U, Bogetto F, Ravizza L. Obsessive-com- pulsive syndromes in older adolescents. Acta Psychiatr Scand 1999;100:447-450.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_86KskU4">The epidemiology of obsessive-compulsive disorder in children and adolescents</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Zohar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F2GTbEV">Child Adolesc Psychiatr Clin N Am</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="445" to="460" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zohar AH. The epidemiology of obsessive-compulsive dis- order in children and adolescents. Child Adolesc Psychiatr Clin N Am 1999;8:445-460.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_JzQy9tS">Functional impairment in children and adolescents with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Piacentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mccracken</surname></persName>
		</author>
		<idno type="DOI">10.1089/104454603322126359</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KGeTepQ">J Child Adolesc Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="61" to="S69" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Piacentini JC, Bergman RL, Keller M, McCracken J. Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psycho- pharmacol 2003;13:S61-S69.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_HWXxHMd">A family study of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Pauls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Alsobrook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
		<idno type="DOI">10.1176/ajp.152.1.76</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sErkPHs">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="76" to="84" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995;152:76-84.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_TnMqkdP">Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Alonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Menchon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pifarre</surname></persName>
		</author>
		<idno type="DOI">10.4088/jcp.v62n07a06</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DqqqgRM">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="535" to="540" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Alonso P, Menchon JM, Pifarre J et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry 2001;62:535-540.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_auzsjdD">Long-term outcome of pediatric obsessive-compulsive disorder: a meta analysis and qualitative review of the literature</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Geller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jenike</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pM4fK7F">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="4" to="13" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stewart SE, Geller DA, Jenike M et al. Long-term outcome of pediatric obsessive-compulsive disorder: a meta analysis and qualitative review of the literature. Acta Psychiatr Scand 2004;110:4-13.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_GMS4CsM">Obsessive-compulsive disorder: a critical review of therapeutic perspectives</title>
		<author>
			<persName><forename type="first">K</forename><surname>Schruers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Koning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Luermans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Haack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Griez</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-0447.2004.00502.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GPN62K2">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="261" to="271" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schruers K, Koning K, Luermans J, Haack MJ, Griez E. Obsessive-compulsive disorder: a critical review of thera- peutic perspectives. Acta Psychiatr Scand 2005;111:261- 271.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_wqENprE">The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MybskFZ">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1006" to="1011" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goodman WK, Price LH, Rasmussen SA et al. The Yale- Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_aNVSq5z">The Yale-Brown obsessive compulsive scale (Y-BOCS): validity</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mazure</surname></persName>
		</author>
		<idno type="DOI">10.1159/000257973</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PYFYndq">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1012" to="1016" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goodman W L, Price LH, Rasmussen SA, Mazure C. The Yale-Brown obsessive compulsive scale (Y-BOCS): valid- ity. Arch Gen Psychiatry 1989;46:1012-1016.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_WhNN2JR">A multidimensional model of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mataix-Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rosario-Campos</forename><surname>Mc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xB4acVT">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="228" to="238" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mataix-Cols D, Rosario-Campos MC, Leckman JF. A mul- tidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005;162:228-238.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_EZd47D5">Exploratory analysis of obsessive compulsive symptom dimensions in children and adolescents: a prospective follow-up study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Delorme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Betancur</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-244x-6-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_azuXABX">BMC Psychiatry</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Delorme R, Bille A, Betancur C et al. Exploratory analysis of obsessive compulsive symptom dimensions in children and adolescents: a prospective follow-up study. BMC Psychiatry 2006;6:1.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_HZkMUY3">Symptom stability in adult obsessive-compulsive disorder: data from a natu-ralistic two-year follow-up study</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mataix-Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Rauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
		<idno type="DOI">10.1176/appi.ajp.159.2.263</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5KT9Gw6">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="263" to="268" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mataix-Cols D, Rauch SL, Baer L et al. Symptom stability in adult obsessive-compulsive disorder: data from a natu- ralistic two-year follow-up study. Am J Psychiatry 2002;159:263-268.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_Au7N6aM">Temporal stability of symptom dimensions in adult patients with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rufer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Grothusen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Peter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hand</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jad.2005.06.003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PGDqBSH">J Affect Disord</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="99" to="102" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rufer M, Grothusen A, Mass R, Peter H, Hand I. Temporal stability of symptom dimensions in adult patients with obsessive-compulsive disorder. J Affect Disord 2005;88:99- 102.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_Xak9Ffd">Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Furr</surname></persName>
		</author>
		<idno type="DOI">10.1037/0022-006x.71.6.1049</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7Pmjtvy">J Consult Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="1049" to="1057" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abramowitz JS, Franklin ME, Schwartz SA, Furr JM. Symptom presentation and outcome of cognitive-behav- ioral therapy for obsessive-compulsive disorder. J Consult Clin Psychol 2003;71:1049-1057.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_EbvhHSr">Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment</title>
		<author>
			<persName><forename type="first">S</forename><surname>Saxena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Maidment</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vapnik</surname></persName>
		</author>
		<idno type="DOI">10.4088/jcp.v63n0105</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_27kCbtk">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="21" to="27" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Saxena S, Maidment KM, Vapnik T et al. Obsessive-com- pulsive hoarding: symptom severity and response to mul- timodal treatment. J Clin Psychiatry 2002;63:21-27.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_rfN4x3j">Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Foa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Goldstein</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0005-7894(78)80013-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jFtUaTv">Behav Ther</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="821" to="829" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foa EB, Goldstein AJ. Continuous exposure and complete response prevention in the treatment of obsessive-com- pulsive neurosis. Behav Ther 1978;9:821-829.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_9APfrbH">Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mataix-Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Marks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Greist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Kobak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SExkRYh">Psychother Psychosom</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="255" to="262" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom 2002;71:255-262.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_eEDHdJu">Symptoms dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rufer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fricke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Moritz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kloss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hand</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-0447.2005.00682.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aXtj2w9">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="440" to="446" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rufer M, Fricke S, Moritz S, Kloss M, Hand I. Symptoms dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand 2006;113:440-446.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_SK3km2J">Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mataix-Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Rauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Manzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jenike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
		<idno type="DOI">10.1176/ajp.156.9.1409</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_85n7Vd8">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="1409" to="1416" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999;156:1409-1416.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_emCzAcV">Chil-drenÕs Yale-Brown Obsessive Compulsive Scale: reliability and validity</title>
		<author>
			<persName><forename type="first">L</forename><surname>Scahill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Riddle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcswiggin-Hardin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Nj8hAXh">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="844" to="852" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Scahill L, Riddle MA, McSwiggin-Hardin M et al. Chil- drenÕs Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997;36:844-852.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Silverman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Albano</surname></persName>
		</author>
		<idno type="DOI">10.1093/med-psych/9780199348343.003.0001</idno>
		<title level="m" xml:id="_hAcD59z">The Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent versions</title>
		<meeting><address><addrLine>San Antonio, TX</addrLine></address></meeting>
		<imprint>
			<publisher>Psychological Corporation</publisher>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Silverman WK, Albano AM. The Anxiety Disorders Inter- view Schedule for DSM-IV: Child and Parent versions. San Antonio, TX: Psychological Corporation, 1996.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_UsQtJg2">Test-retest reliability of anxiety symptoms and diagnoses with Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Silverman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Saavedra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Pina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CmJJFpN">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="937" to="944" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Silverman WK, Saavedra LM, Pina AA. Test-retest reli- ability of anxiety symptoms and diagnoses with Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions. J Am Acad Child Adolesc Psychiatry 2001;40:937-944.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_vspBRwD">Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Piacentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mccracken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Barrios</surname></persName>
		</author>
		<idno type="DOI">10.1207/153744202760082595</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7NgnZz5">J Clin Child Adolesc Psychol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="335" to="342" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wood JJ, Piacentini JC, Bergman RL, McCracken J, Barrios V. Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions. J Clin Child Adolesc Psychol 2002;31:335-342.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_qEzWCCz">Psychometric evaluation of the ChildrenÕs Yale-Brown Obsessive Compulsive Scale</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fX2ZFZb">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="91" to="98" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Murphy TK, Geffken GR et al. Psychometric evaluation of the ChildrenÕs Yale-Brown Obsessive Com- pulsive Scale. Psychiatry Res 2004;129:91-98.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_vEwHPCk">Interrater reliability and clinical efficacy of ChildrenÕs Yale-Brown Obsessive-Compulsive Scale in an outpatient setting</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Yucelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodopman-Arman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Topcuoglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Yazgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fisek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Axgjdah">Compr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="48" to="53" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yucelen AG, Rodopman-Arman A, Topcuoglu V, Yazgan MY, Fisek G. Interrater reliability and clinical efficacy of ChildrenÕs Yale-Brown Obsessive-Compulsive Scale in an outpatient setting. Compr Psychiatry 2006;47:48-53.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_FeC2xvm">Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Healy-Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>March</surname></persName>
		</author>
		<idno type="DOI">10.1097/00004583-200401000-00014</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YJS7wYt">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="46" to="62" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Barrett P, Healy-Farrell L, March JS. Cognitive-behav- ioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry 2004;43:46-62.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_k6YsTZt">Cognitive-behavioral therapy, sertraline, and their combination for children and adolescents with obsessivecompulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">Pediatric</forename><surname>Obsessive-Compulsive</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Disorder</forename><surname>Treatment</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Study</forename><surname>Team</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VkYNXg9">JAMA</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="1969" to="1976" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pediatric Obsessive-Compulsive Disorder Treatment Study Team. Cognitive-behavioral therapy, sertraline, and their combination for children and adolescents with obsessive- compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) Randomized Controlled Trial. JAMA 2004;292:1969-1976.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_U4yfwju">Cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Merlo</surname></persName>
		</author>
		<idno type="DOI">10.1097/chi.0b013e31803062e7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UeGHKkz">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="469" to="478" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Geffken GR, Merlo LJ et al. Cognitive-behav- ioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 2007;46:469-478.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_wmxXsqT">Assessment manual for psychopharmacology, revised</title>
		<author>
			<persName><forename type="first">W</forename><surname>Guy</surname></persName>
		</author>
		<idno>ABM 76-366</idno>
	</analytic>
	<monogr>
		<title level="s" xml:id="_KS7DvPK">DHEW publication</title>
		<imprint>
			<date type="published" when="1976">1976</date>
			<publisher>US Government Printing Office</publisher>
			<pubPlace>Washington DC</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Guy W. Assessment manual for psychopharmacology, re- vised (DHEW publication ABM 76-366). Washington DC: US Government Printing Office, 1976.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_RxdkANG">Rating scales and assessment instruments for use in pediatric psychopharmacology research</title>
		<author>
			<persName><forename type="first">National</forename><surname>Institute</surname></persName>
		</author>
		<author>
			<persName><surname>Health</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2HKKR8V">Psychopharmacol Bull</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="839" to="843" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
	<note type="raw_reference">National Institute of Mental Health. Rating scales and assessment instruments for use in pediatric psychophar- macology research. Psychopharmacol Bull 1985;21:839- 843.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<idno type="DOI">10.1176/appi.books.9780890423349</idno>
		<title level="m" xml:id="_mVChbSh">American Psychiatric Association. Diagnostic and statistic manual of mental disorders</title>
		<meeting><address><addrLine>Washington, DC</addrLine></address></meeting>
		<imprint>
			<publisher>Author</publisher>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>4th ed. -text revision</note>
	<note type="raw_reference">American Psychiatric Association. Diagnostic and statistic manual of mental disorders (4th ed. -text revision). Washington, DC: Author, 2000.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_Hv4pS2C">Best estimate of lifetime psychiatric diagnosis: a methodological study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sholomskas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Belanger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Weissman</surname></persName>
		</author>
		<idno type="DOI">10.1001/archpsyc.1982.04290080001001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FECaG3k">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="879" to="883" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diag- nosis: a methodological study. Arch Gen Psychiatry 1982;39:879-883.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_KAh5MGV">Symptoms of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Grice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boardman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cR54685">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="page" from="911" to="917" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leckman JF, Grice DE, Boardman J et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997;154:911-917.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_xxhzMm3">Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Summerfeldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Antony</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Swinson</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0005-7967(98)00134-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Zdqm22C">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="297" to="311" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Summerfeldt LJ, Richter MA, Antony MM, Swinson RP. Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav Res Ther 1999;37:297-311.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_WtTTTwc">Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders</title>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DgPzmfc">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="18" to="23" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Baer L. Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 1994;55:18-23.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_DzjGYk3">The Obsessive-Compulsive Inventory: development and validation of a short version</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Foa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Huppert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Leiberg</surname></persName>
		</author>
		<idno type="DOI">10.1037/1040-3590.14.4.485</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gerbxev">Psychol Assess</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="485" to="496" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foa EB, Huppert JD, Leiberg S et al. The Obsessive-Com- pulsive Inventory: development and validation of a short version. Psychol Assess 2002;14:485-496.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_XpBm4xc">Family-based treatment of early-onset obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karitani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Leonard</surname></persName>
		</author>
		<idno type="DOI">10.1089/104454603322126368</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8evg4KW">J Child Adolesc Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="71" to="S80" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Freeman JB, Garcia AM, Fucci C, Karitani M, Miller L, Leonard HL. Family-based treatment of early-onset obsessive-compulsive disorder. J Child Adolesc Psycho- pharmacol 2003;13:S71-S80.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_XHUEfd6">The principles of extinction and differential reinforcement of other behaviors in the intensive cognitive behavioral treatment of primarily obsessional pediatric OCD</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lewin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TfZzpV9">Clin Case Stud</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="511" to="521" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fernandez M, Storch EA, Lewin A, Murphy TK, Geffken GR. The principles of extinction and differential reinforcement of other behaviors in the intensive cognitive behavioral treatment of primarily obsessional pediatric OCD. Clin Case Stud 2006;5:511-521.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_tUpUUnW">Long-term sertraline treatment of children and adolescents with obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>March</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qexT3gG">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1175" to="1181" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cook EH, Wagner KD, March JS et al. Long-term sertraline treatment of children and adolescents with obsessive- compulsive disorder. J Am Acad Child Adolesc Psychiatry 2001;40:1175-1181.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_XnDbEw9">An open trial of cognitive-behaviour therapy in children and adolescents with obsessive-compulsive disorder administered in regular outpatient clinics</title>
		<author>
			<persName><forename type="first">R</forename><surname>Valderhaug</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Gotestam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Piacentini</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brat.2006.04.011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SZtBKCH">Behav Res Therapy</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="577" to="589" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Valderhaug R, Larsson B, Gotestam KG, Piacentini J. An open trial of cognitive-behaviour therapy in children and adolescents with obsessive-compulsive disorder adminis- tered in regular outpatient clinics. Behav Res Therapy 2007;45:577-589.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_tQQTGkE">The Yale-Brown Obsessive Compulsive Scale: factor analysis, construct validity, and suggestions for refinement</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Deacon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.janxdis.2004.04.009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RCXDZVm">J Anxiety Disord</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="573" to="585" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Deacon BJ, Abramowitz JS. The Yale-Brown Obsessive Compulsive Scale: factor analysis, construct validity, and suggestions for refinement. J Anxiety Disord 2005;19:573- 585.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_7bnE24J">Factor structure of the ChildrenÕs Yale-Brown Obsessive-Compulsive Scale</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
		<idno type="DOI">10.1207/s15374424jccp3402_10</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zQUSP5a">J Clin Child Adolesc Psychol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="312" to="319" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Murphy TK, Geffken GR et al. Factor structure of the ChildrenÕs Yale-Brown Obsessive-Compulsive Scale. J Clin Child Adolesc Psychol 2005;34:312-319.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_wx6SGMp">The Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Shapira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dimoulas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<idno type="DOI">10.1002/da.20088</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7hUXRkS">Depress Anxiety</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="28" to="35" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Shapira NA, Dimoulas E, Geffken GR, Murphy TK, Goodman WK. The Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited. Depress Anxiety 2005;22:28-35.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
